IFP Advisors’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
PGCM
IFP Advisors's DNA Position: Q3 2026 in Review
IFP Advisors sold out of Ginkgo Bioworks (DNA) in Q3 2026, closing a stake of 421 shares — an estimated $4.17K sold.
IFP Advisors first reported a position in DNA in Q3 2021 and held it in 19 quarters. The position peaked at $991K in Q3 2022. 33 funds tracked by Wall St. Rank hold DNA as of Q3 2026.
- IFP Advisors reported no remaining Ginkgo Bioworks position as of Q3 2026 after selling out during the quarter.
- IFP Advisors sold 421 Ginkgo Bioworks shares in Q3 2026, an estimated $4.17K.
- IFP Advisors first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 19 quarters.
- IFP Advisors's Ginkgo Bioworks position peaked at $991K in Q3 2022.
- 33 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.
Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.